Remedy, a gaming company, has announced that sales of its latest game have been strong, with an average price that remains high. The company is already looking ahead to future projects and the possibility of self-publishing games.
In their business overview for the beginning of the year, Remedy reported an operating loss of EUR 2.1 million and a turnover of EUR 10.8 million. Analysts had predicted a larger loss at EUR 7.5 million, with turnover at EUR 7.1 million. However, the company attributes its recent growth to the success of Alan Wake 2, which was released at the end of last year and has sold over 1.3 million copies as of February.
Tero Virtala, CEO of Remedy, stated that their focus is on developing new projects, including additional content for Alan Wake 2. Despite this, their outlook for the year remains unchanged with expectations of increased turnover and improved operating profit.
The decision to self-publish or find a new partner for upcoming games will impact Remedy’s future success. Projects such as Codename Condor and Control 2 are currently in development and will affect their financial results in the coming year.
Despite these challenges, Remedy is optimistic about its future prospects and remains committed to delivering high-quality gaming experiences to its fans.
